One of Africa's leading medical and social research centres into Aids and HIV
11.jpg
13.jpg

2005 Publications - 2005 Publications (Part II)

Article Index
2005 Publications
2005 Publications (Part II)
2005 Publications (Part III)
2005 Publications (Part IV)
2005 Publications (Part V)
2005 Publications (Part VI)
All Pages

Group publications: 2005

The Breastfeeding and HIV International Transmission Study Group. Mortality among HIV-1 infected women according to children’s feeding modality: an individual patient data meta-analysis. J Acquir Immune Defic Syndr. 2005;39:430-438.

Submitted publications: 2005

Heyer AS, Ogunbanjo GA. Adherence to HIV Anti-retroviral Therapy Part I – Factors Related to Treatment Regimen. Submitted to SA Family Practice, received on 7 September 2005.

Book chapters: 2005

Mfecane S, Struthers H, Gray G and McIntyre J. How masculinity and lifestyle of drinking in shebeens interact to create risks for transmission of HIV/AIDS in a black township in South Africa. In Anita Hardin and Diana Ginson (eds). Rethinking Gender and Masculinities. Confronting issues of health. 2005 Nederlands: Spinhuis publishers.

Oral presentations: 2005

De Bruyn G, Diagnosis of childhood tuberculosis. 1st Priorities in AIDS Care and Treatment conference, 2005.

Dladla S, Robertson G. Couple HIV counselling and testing as entry to treatment and care. 1st Priorities in AIDS Care and Treatment conference, 2005.

Grey GE. The current debate: Routine HIV screening or VCT? (Plenary) 1st Conference on Priorities in AIDS Care and Treatment, Muldersdrift, Johannesburg, 19 – 22 April 2005

Gray G, van Niekerk R, Urban M, Violari A, McIntyre J, Martinson N, PEP Study Group. Death and hospital admissions in infants born to HIV-infected women. Abstract 803. 12th Conference on Retroviruses and Opportunistic Infections. 22-25 February 2005. Boston, MA.

Heyer A, Steyn J, Pronyk P, Gray G, McIntyre J, Struthers H, Martinson N. Prevalence and risk factors for pre-malignant cervical lesions in HIV infected women. Abstract MoPe11.2.33 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro.

Johnson J, Lil JF, Morris L, Martinson N, Gray G, J McIntyre J, Henein W. Resistance emerges in the majority of women provided intrapartum single-dose nevirapine. Abstract 100. 12th Conference on Retroviruses and Opportunistic Infections. 22-25 February 2005. Boston, MA.

Jooste I, Struthers H. Wanting more from the media: audiences in high HIV prevalence areas say news does not represent their reality. 3rd African Conference for the Research on the Social Aspects of the HIV / AIDS, “Bridging the gap between policy, research and interventions”, Dakar, Senegal October 10th -14th 2005

Martinson N. An integrated approach to primary HIV care. 1st Conference on Priorities in AIDS Care and Treatment, Muldersdrift, Johannesburg, 19 – 22 April 2005

Martinson N, Heyer A, Steyn J, Struthers H, McIntyre J, Gray G, Pronyk P. Does WHO clinical stage reliably predict who should receive ARV treatment? Abstract WeFO0304, 3rd Conference on HIV Pathogenesis and Treatment. 24-27 July 2005, Rio de Janeiro .

Martinson N, Lupondwana P, Morris L, Ntsala M, Puren A, Chezzi C, Dhlamini P, Cohen S, Gray G, Steyn J McIntyre J. Effectiveness of Single-dose Nevirapine in a Second Pregnancy. Abstract 103. 12th Conference on Retroviruses and Opportunistic Infections. 22-25 February 2005. Boston, MA.

McIntyre JA. Controversies in the use of nevirapine for the prevention of mother-to-child transmission of HIV. (Plenary) 12th Conference on Retroviruses and Opportunistic Infections, Boston, February 22 -2 5 2005

McIntyre JA. New developments in the prevention of mother-to-child transmission of HIV. (Plenary) 1st Conference on Priorities in AIDS Care and Treatment, Muldersdrift, Johannesburg, 19 – 22 April 2005

McIntyre JA. Addition of short course Combivir (CBV) to single dose Viramune (sdNVP) for prevention of mother to child transmission (pMTCT) of HIV-1 can significantly decrease the subsequent development of maternal NNRTI-resistant virus. 3rd IAS conference on HIV pathogenesis and Treatment. Rio de Janeiro, 24 – 27 July 2005

McIntyre JA. New directions in the science of AIDS prevention. (Plenary) University of the Witwatersrand Faculty of Health Sciences Research Day, 4 August 2005

McIntyre JA. The Impact of HIV on pregnant women in South Africa. (Opening Plenary) 32nd National Conference of the South African Society of Obstetricians and Gynaecologists, Drakensberg, 4 – 7 September 2005

McIntyre JA. Antiretroviral treatment in South Africa. New approaches to HIV management. Centes Garde Symposium, Beijing China, 3 – 6 December 2005

Modiba P. VCT: The entry point to HIV care and treatment. 1st Conference on Priorities in AIDS Care and Treatment, Muldersdrift, Johannesburg, 19 – 22 April 2005

Palmer S, Boltz V, Maldarelli F, Martinson N, Gray G, McIntyre J, Mellors J, Morris L, Coffin J. Persistence of NNRTI-r resistant variants after single-dose nevirapine in HIV-1 subtype-C-infected women. Abstract 101. 12th Conference on Retroviruses and Opportunistic Infections. 22-25 February 2005. Boston, MA.

Pato, S., 2005, Challenges in the development and implementation of the informed consent process. Workshop on the Informed Consent in HIV Prevention Trials, 16 – 18 May 2005, New York.

Vardas E, Panteleo G, Bart PA, Robinson A, Thomas R, McIntyre J, Bogoshi M, Mayaphi S, Fast P, Schmit C, Gilmour J, Tarragona T, Smith C, Dally L. Safety and immunogenicity of MVA.HIVA by 3 different routes. (329P). AIDS Vaccine Conference, Montreal, September 6-9, 2005.

Violari A. ARV treatment in pregnancy. 1st Conference on Priorities in AIDS Care and Treatment, Muldersdrift, Johannesburg, 19 – 22 April 2005.